Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 16, 2022
Two opposing “agendas” keep skin mutant cell clusters at an impasse
From the Beronja lab, Human Biology Division
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Researchers identify new way skin stops tumor growth
‘Oncogene-induced differentiation’ joins two other strategies for counteracting potentially cancer-causing DNA changes
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health
Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma
Skin cancer: 9 things to know to lower your risk
From cover-ups to caffeine, here are some tips for protecting your skin during the summer and all year long
Tanning bed use declines, new study shows
Rate of use has dipped slightly but 10 million Americans are still using tanning salons regularly
As U.S. cases of skin cancer rise, costs skyrocket, too
Five million American adults are diagnosed each year at a cost of $8.1 billion, new CDC study finds
Surgeon general: Stop sunbathing and get out of the tanning bed
New report issues ‘call to action’ in wake of rising skin cancer rates
Tanning beds get a black label warning
Citing skin cancer risks, new FDA regulations caution against use by teens
Tanning beds in the hot seat as skin cancer rates jump
Incidence of melanoma has increased dramatically in last four decades, new study finds
After beating rare cancer, 'signing up for Obliteride was a no-brainer'
Keith Winkle will come back to Seattle from Alaska to ride because research saved his life; the Aug. 9-11 bike ride will raise funds to benefit Fred Hutchinson Cancer Research Center
‘Tumor Paint’ research of pediatric oncologist Jim Olson featured in short film -- a Sundance Festival finalist
Three-minute documentary about Seattle researcher’s discovery is online for viewing and voting
New squamous cell carcinoma drug target discovered
Vasioukhin and colleagues find alpha-catenin protein acts as a tumor suppressor, cell growth control mechanism revealed